Drug Trial Radar · NCT05410860
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Jun 30, 2022
Primary completion
Aug 2, 2024
Study completion Dec 10, 2024
Sponsor
- Lead sponsor
- Corxel PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Milestone Pharmaceuticals Inc.
- First posted
- Jun 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine whether etripamil nasal spray (NS) self-administered by Chinese patients is superior to placebo at terminating episodes of PSVT in an at-home setting; To evaluate the efficacy of etripamil NS self-administered by Chinese patients compared with placebo on a range of clinical markers. To evaluate the safety of etripamil NS self-administered by Chinese patients compared with placebo
Conditions
- Tachycardia, Supraventricular
- Paroxysmal Supraventricular Tachycardia
Interventions
Etripamil NS 70 mgDrug
Etripamil NS 70 mg will be administered via the Aptar Pharma Nasal Spray Bidose System, supplied as prefilled devices packaged into child-resistant boxes with instructions for use provided in the study drug box.
PlaceboDrug
Placebo will be administered via the Aptar Pharma Nasal Spray Bidose System, supplied as prefilled devices packaged into child-resistant boxes with instructions for use provided in the study drug box.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to an adjudicated termination of a positively adjudicated episode of PSVT and conversion to sinus rhythm (SR) for at least 30 seconds within 30 minutes of start of study drug dosingTime frame: Within 30 minutes of start of study drug dosing.
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
Baotou Central Hospital
Baotou, China
The First Affiliated Hospital of Baotou Medical College
Baotou, China
Beijing Anzhen Hospital; Capital Medical University
Beijing, China
Beijing Hospital
Beijing, China
Beijing Tongren Hospital, Capital Medical University
Beijing, China
Chui Yang Liu Hospital Affiliated to Tsinghua University
Beijing, China
Peking Union Medical College Hospital
Beijing, China
The Central Hospital of China Aerospace Corporation
Beijing, China
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China
The First Hospital of Jilin University
Ch’ang-ch’un, China
The Third Xiangya Hospital of Central South University
Changsha, China
Xiangya Hospital, Central South University
Changsha, China
Changzhou No.2 People's Hospital
Changzhou, China
The First Affiliated Hospital of Chengdu Medical College
Chengdu, China
Affiliated Zhongshan Hospital of Dalian University
Dalian, China
People's Hospital of Deyang City
Deyang, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Nanfang Hospital of Southern Medical University
Guangzhou, China
Guizhou Provincial People's Hospital
Guiyang, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
The First People's Hospital of Hangzhou Linping District
Hangzhou, China
Zhejiang Provincial People's Hospital
Hangzhou, China
Huai'an First People's Hospital
Huai'an, China
Huainan First People's Hospital
Huainan, China
Huizhou Municipal Central Hospital
Huizhou, China
Jinan Central Hospital
Jinan, China
Shandong Province Qianfoshan Hospital
Jinan, China
The First Affiliated Hospital of Jinzhou Medical University
Jinzhou, China
Lanzhou University Second Hospital
Lanzhou, China
Lishui Municipal Central Hospital
Lishui, China
The First Affiliated Hospital of Henan Science and Technology University
Luoyang, China
Mianyang Central Hospital
Mianyang, China
The Nanchang Third Hospital
Nanchang, China
The Second Affiliated Hospital of Nanchang University
Nanchang, China
Jiangsu Province Hospital
Nanjing, China
Nanjing Drum Tower Hospital
Nanjing, China
Guangxi Zhuang Autonomous Region People's Hospital
Nanning, China
The second affiliated Hospital of Guangxi Medical University
Nanning, China
Nanyang Second General Hospital
Nanyang, China
Ningbo First Hospital
Ningbo, China
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.